Detalles de la búsqueda
1.
Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune-Biological Evaluation and Case Report.
Int J Mol Sci
; 22(12)2021 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34200673
2.
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy.
Int J Mol Sci
; 21(15)2020 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717807
3.
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach.
Front Oncol
; 12: 911579, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185285
4.
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis.
Life (Basel)
; 11(11)2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833111
5.
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.
Cells
; 9(9)2020 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854442
6.
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade.
J Immunother Cancer
; 8(1)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32554614
7.
Is There Already a Need of Reckoning on Cancer Immunotherapy?
Front Pharmacol
; 12: 638279, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33841155
8.
Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?
Front Immunol
; 11: 1208, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574270
9.
On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer.
Transl Lung Cancer Res
; 9(5): 1712-1719, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209592
Resultados
1 -
9
de 9
1
Próxima >
>>